$ACT Company News AstraZeneca to buy Actavis

New Post Public Reply Private Reply Replies (0) Message Board

Feb 15, 2015 at 12:14 PM

$ACT Company News

AstraZeneca to buy Actavis respiratory-drug unit 3:20 a.m. Feb. 5, 2015 - MarketWatch.com
Allergan profit surges on higher sales 5:50 p.m. Feb. 4, 2015 - MarketWatch.com
Options remain limited for growth-stock speculators 3:16 p.m. Jan. 22, 2015 - The Trading Deck
These unloved stocks may beat the S&P 500 again in 2015 10:56 a.m. Jan. 20, 2015 - Brett Arends
10 hated stocks your portfolio will love 6:01 a.m. Jan. 20, 2015 - Brett Arends
Actavis expects profit to beat expectations 9:44 a.m. Jan. 12, 2015 - Michael Calia
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
10 stocks that can withstand a rocky 2015 12:31 p.m. Dec. 31, 2014 - The Trading Deck
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Here are the best S&P 500 stocks and sectors of 2014 1:52 p.m. Dec. 29, 2014 - Philip van Doorn
2014 was the year that all predictions were wrong 11:29 a.m. Dec. 26, 2014 - Marek Fuchs
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Adamas' stock soars after dementia treatment approval 8:24 a.m. Dec. 24, 2014 - Tomi Kilgore
Second 2% S&P 500 spike signals strong bull trend 11:23 a.m. Dec. 19, 2014 - Michael Ashbaugh
What a week: Botox haze, merger Monday and The Tanned One 9:19 a.m. Nov. 21, 2014 - Marek Fuchs
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Nov. 20, 2014 - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
S&P, Dow ring up records Tuesday 4:35 p.m. Nov. 18, 2014 - Barbara Kollmeyer
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee

Jim Cramer's Top Stock Picks: ACT PCLN CLX HAIN WWAV NVAX 6:00 a.m. Feb. 14, 2015 - TheStreet.com
How Alger’s Patrick Kelly Stays Ahead of the Game 2:15 a.m. Feb. 14, 2015 - Barrons.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:03 p.m. Feb. 13, 2015 - TheStreet.com
Salix, Top Drug Stocks Rally As Merger Mania Heats Up 5:08 p.m. Feb. 13, 2015 - Investors Business Daily
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More 4:00 p.m. Feb. 13, 2015 - Seeking Alpha
AstraZeneca's Q4 Misses Profit Estimates, But Management Stays Upbeat 11:29 a.m. Feb. 13, 2015 - GuruFocus.com
FDA accepts Pfizer's NDA for abuse-deterrent opioid 11:22 a.m. Feb. 13, 2015 - Seeking Alpha
Ackman vs. Icahn: How Two Billionaires, Former Adversaries, Stack Up 11:14 a.m. Feb. 13, 2015 - TheStreet.com
Will Masimo Corp (MASI) Disappoint Q4 Earnings Estimates? - Analyst Blog 10:30 a.m. Feb. 13, 2015 - Zacks.com
Can Radius Health (RDUS) Surprise This Earnings Season? - Analyst Blog 10:06 a.m. Feb. 13, 2015 - Zacks.com
Actavis divests pharma outsourcing business to private equity firm 9:45 a.m. Feb. 13, 2015 - Seeking Alpha
Ironwood Pharmaceuticals Cuts Loss on Higher Revenues - Analyst Blog 9:22 a.m. Feb. 13, 2015 - Zacks.com
Actavis To Divest Pharmatect To TPG, No Terms Disclosed 7:33 a.m. Feb. 13, 2015 - benzinga.com
Allergan (AGN) Stock: Keep On Buying This Botox Baron 12:00 a.m. Feb. 13, 2015 - InvestorPlace.com
Don't Discount Bill Ackman 12:13 p.m. Feb. 11, 2015 - Seeking Alpha
3 Stocks Boosting The Drugs Industry Higher 12:10 p.m. Feb. 11, 2015 - TheStreet.com
Will Kite Pharma (KITE) Disappoint this Earnings Season? - Analyst Blog 10:40 a.m. Feb. 11, 2015 - Zacks.com
CVRs - The Good, The Bad And The Ugly 1:40 a.m. Feb. 11, 2015 - Seeking Alpha
Actavis to Divest U.S. Rights of Doryx to Mayne Pharma - Analyst Blog 3:41 p.m. Feb. 10, 2015 - Zacks.com
DaVita Healthcare (DVA): What's in Store for Q4 Earnings? - Analyst Blog 3:30 p.m. Feb. 10, 2015 - Zacks.com

Actavis Launches Generic Pulmicort RESPULES® 4:28 p.m. Feb. 13, 2015 - PR Newswire - PRF
Actavis to Divest Pharmatech to TPG 8:30 a.m. Feb. 13, 2015 - PR Newswire - PRF
World Intravenous (IV) Iron Drugs Industry 12:39 p.m. Feb. 10, 2015 - PR Newswire - PRF
Actavis to Divest Doryx® to Mayne Pharma 5:23 p.m. Feb. 9, 2015 - PR Newswire - PRF
Fresh Deals on W-Street: Special Research on Hospira, BT Group, Actavis, Ball, and Frontier 8:10 a.m. Feb. 6, 2015 - PR Newswire - PRF
Galena Biopharma Announces Orexo's Filing of a Patent Infringement Lawsuit Against Actavis Concerning Abstral(R) (fentanyl) Sublingual Tablets in the U.S. 7:05 a.m. Feb. 5, 2015 - GlobeNewswire
Actavis to Divest Rights to Branded Respiratory Portfolio in the U.S. and Canada to AstraZeneca 2:05 a.m. Feb. 5, 2015 - PR Newswire - PRF
Actavis Announces FDA Acceptance of sNDA to Expand TEFLARO® (ceftaroline fosamil) Labeling 8:00 a.m. Feb. 4, 2015 - PR Newswire - PRF
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - BusinessWire - BZX
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - PR Newswire - PRF
Actavis to Acquire Auden Mckenzie for 306M GBP 7:30 a.m. Jan. 26, 2015 - PR Newswire - PRF
Richter and Actavis Announce Positive Phase III Results for Cariprazine in the Prevention of Relapse in Patients with Schizophrenia 2:00 a.m. Jan. 20, 2015 - PR Newswire - PRF
Actavis Launches U.S. Generic Specialty Injectable Portfolio 8:00 a.m. Jan. 13, 2015 - PR Newswire - PRF
Equities Updates on Health Care Sector - Johnson and Johnson, VIVUS, Actavis, Covance, and Sequenom 8:35 a.m. Jan. 12, 2015 - PR Newswire - PRF
Actavis Announces Exceptional Preliminary Fourth Quarter 2014 Performance 8:30 a.m. Jan. 12, 2015 - PR Newswire - PRF
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis’ Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:02 a.m. Jan. 12, 2015 - BusinessWire - BZX
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
Actavis Confirms Appeals Court Grants Expedited Appeal of Ruling Requiring Continued Distribution of NAMENDA® IR 3:54 p.m. Jan. 6, 2015 - PR Newswire - PRF
Actavis and Gedeon Richter Announce FDA Receipt of NDA Resubmission for Cariprazine 2:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Timing is Crucial, Upside Analysis: Research Reports on Alder, Sky Solar, CNinsure, Raytheon, and Actavis 9:00 a.m. Dec. 29, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Battery Testing Market to Reach $45 Billion by 2033

There's a gold rush happening in the battery testing market, as ambitious as any I've seen in my trading years. The market's taking off faster than a Wall Street trader on a bull market open, projected to skyrocket from $13.03 billion in 2026 to $45.06 billion by 2033. That's a hefty 19.4% compound annual growth rate, a pace that'll have big money and new players...

JELD-WEN Alters Exchange Consideration for 2027 Notes

Navigating the Turbulent Waters of Note Exchanges Well folks, it looks like JELD-WEN Holding, Inc. is making waves again. The company has decided to shake things up a bit with a new twist on the note exchange comedy script. They’re altering the terms of the late exchange consideration for their outstanding 4.875% Senior Notes due 2027, making the latecomers to the party...

Asset Based Lending's $200M Securitization: A Power Move

Well, folks, Asset Based Lending (ABL) in Jersey City just pulled a rabbit out of a challenging market hat, hammering out their heftiest securitization yet—a crisp $200 million deal. This isn't just pocket change, even for a seasoned player like ABL. Let's dive into what makes this move not just hefty in size, but a strategic punch in the current landscape of...

Porte Brown Hits #3 for Young Accountants in 2026

Fresh Faces Rank Porte Brown High Now here's a thing most big-name firms might envy—Porte Brown nabbed the #3 spot on Accounting Today's 2026 list of Best Firms for Young Accountants. This isn't some fly-by-night recognition; it speaks to their whole gig—nurturing, training, and growing young talent in the world of numbers. When you talk about setting the bar for...

Yael Eckstein Honored for Advancing Faith Collaborations

Recognition for Bridging Communities It's not every day you hear about someone getting a pat on the back as broad as a lifetime achievement award. Yet, Yael Eckstein, President and Global CEO of the International Fellowship of Christians and Jews (The Fellowship), managed just that during an elegant gala in Jerusalem. The Black Christian Leadership Council on Israel...

Frontera Energy: Solid Gains Amid Strategic Expansions

Thriving in a Complex Energy World You know, for Frontera Energy Corporation, it's not just about tossing around tanker loads of cash—it’s about working those numbers into something real. Their Q3 2026 gives us a peep into how they’re keeping the hot iron pressed against opportunity. With a net income of $11.7 million and adjusted EBITDA jumping 16% to top $34.8...

Oman Unveils Groundbreaking China Investment Package

Transforming Oman-China Relations Through Investment Let me tell you, this one's a hefty shake-up in the Middle East’s economic scene. Oman’s pulling in billions with its latest move, signing the biggest bundle of investment agreements in its history, all thanks to some heavy-handed diplomacy between the Sultanate’s top brass and Chinese financial muscle. We're...

Reagan Institute's New Fellowship: Academic Game-Changer

Aiming for an Academic Revival There’s hope on the horizon for academics wrestling to find their foothold among hallowed university halls. The Reagan Institute Society of Fellows is opening new doors for early career scholars. With heavyweight partners like Dartmouth and George Washington University joining forces, this is a solid lifeline amidst a sea of fading...

BrightView's Tumbling Shares Prompt Investor Inquiry

BrightView's Financial Quagmire: Investor Alarm Bells Ring Just when you thought it couldn't get any rockier for BrightView Holdings (NYSE: BV), here comes another gut punch. Their Development Services segment—once a promising player—felt like it dropped off a cliff, tumbling by almost 18%. If you were counting on those revenues to keep things afloat, well, it seems...

NKT's Power Cable Triumph: Elbe Crossing Success

NKT's Sweeping Success at the Elbe Crossing In one spellbinding leap, NKT just crossed the River Elbe with their specially engineered power cables like a high-wire act over a natural canyon. We're talking about the SuedLink project—a massive undertaking to link up Germany's power grid. Now, NKT didn't just drop a couple of cables under this river. They delivered 525 kV...